Interpharm Holdings, Inc.
IPAH
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Revenue | 16.21M | 17.72M | 15.37M | 19.91M | 17.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.21M | 17.72M | 15.37M | 19.91M | 17.48M |
| Cost of Revenue | 13.95M | 16.64M | 13.09M | 13.54M | 13.44M |
| Gross Profit | 2.27M | 1.08M | 2.28M | 6.38M | 4.04M |
| SG&A Expenses | 3.30M | 3.77M | 3.69M | 3.92M | 3.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.15M | 23.87M | 22.74M | 22.16M | 21.43M |
| Operating Income | -3.94M | -6.15M | -7.37M | -2.25M | -3.95M |
| Income Before Tax | -4.92M | -6.90M | -7.85M | -2.60M | -6.03M |
| Income Tax Expenses | 5.98M | -- | 1.86M | -746.00K | -1.91M |
| Earnings from Continuing Operations | -10.90M | -6.90M | -9.71M | -1.85M | -4.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.90M | -6.90M | -9.71M | -1.85M | -4.12M |
| EBIT | -3.94M | -6.15M | -7.37M | -2.25M | -3.95M |
| EBITDA | -3.02M | -5.25M | -6.62M | -1.68M | -3.42M |
| EPS Basic | -0.21 | -0.10 | -0.15 | -0.04 | -0.07 |
| Normalized Basic EPS | -0.05 | -0.07 | -0.07 | -0.02 | -0.04 |
| EPS Diluted | -0.21 | -0.10 | -0.16 | -0.04 | -0.07 |
| Normalized Diluted EPS | -0.05 | -0.07 | -0.07 | -0.02 | -0.04 |
| Average Basic Shares Outstanding | 66.74M | 66.20M | 65.81M | 65.38M | 65.06M |
| Average Diluted Shares Outstanding | 66.74M | 66.20M | 65.81M | 65.38M | 65.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 0.00% | 0.00% | -3.01% |